The Amyloidosis Channel is supported with funding from Prothena (Silver).
The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
SOHO Italy 2022 | The importance of using multidisciplinary approaches when treating rare hematological malignancies
Alessandra Romano, MD, PhD, University of Catania, Catania, Italy, discusses the importance of using multidisciplinary approaches when diagnosing and treating patients with Waldenström’s macroglobulinemia (WM), amyloidosis, and systemic mastocytosis (SM), and further highlights the promise of novel immunotherapeutic approaches. This interview took place at the 4th Society of Hematologic Oncology (SOHO) Italy Annual Conference, held in Rome, Italy.
